NCOMS : North Carolina Oncology Management Society NCOMS : North Carolina Oncology Management Society NCOMS : North Carolina Oncology Management Society NCOMS : North Carolina Oncology Management Society NCOMS : North Carolina Oncology Management Society
NCOMS : North Carolina Oncology Management Society
NCOMS : North Carolina Oncology Management Society
NCOMS : North Carolina Oncology Management Society
Home
About Us
Member Center
Legislative News
Reimbursement
Education
Patient Advocacy
Conference Details
How to Join
Cancer News
Calendar
Contact Us
Our Sponsors
Links
NCOMS : North Carolina Oncology Management Society
Corrections to Covered Indications for Docetaxel and Gemcitabine

 
CIGNA Government Services

April 8, 2008

Corrections to Covered Indications for Docetaxel and Gemcitabine

(Note: There were covered indications incorrectly listed in the articles on Covered Indications for Chemotherapy Drugs and their Adjuncts)

Docetaxel (Taxotere) J9170 140.0 to 151.9, 158.9, 160.0 to 162.9, 174.0 to 175.9, 183.0-183.9, 185, 188.0-188.9, 195.0
Gemcitabine J9201 156.0-156.9, 157.0 to 158.9, 162.2-162.9, 164.2, 164.3, 164.8, 164.9, 174.0 to 175.9, 181, 183.0-183.9, 186.0-186.9, 188.0-188.9, 194.4, 200.00 to 202.98


An ISO 9001:2000 certified company

Home | About Us | Careers | Site Map | Disclaimer | Web Site Feedback | Contact Us


Centers for Medicare & Medicaid Services

NCOMS : North Carolina Oncology Management Society